These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2851784)

  • 1. Silent human pancreatic glucagonoma and "A" nesidioblastosis.
    Balas D; Senegas-Balas F; Delvaux M; Bertrand C; Fagot-Revurat P; Rumeau JL; Ribet A
    Pancreas; 1988; 3(6):734-9. PubMed ID: 2851784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A malignant tumor of the pancreas producing glucagonoma syndrome: immunocytochemistry and ultrastructure of liver metastases and comparison with the primary tumor.
    Bani D; Bani Sacchi T; Biliotti G
    Pancreas; 1989; 4(4):492-5. PubMed ID: 2548178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
    Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
    Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
    Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
    Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagonomas. Ultrastructure and immunocytochemistry.
    Warner TF; Block M; Hafez GR; Mack E; Lloyd RV; Bloom SR
    Cancer; 1983 Mar; 51(6):1091-6. PubMed ID: 6295622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron microscopic and immunoelectron microscopic demonstration of pancreatic polypeptide cells in glucagonoma: colocalization of pancreatic peptide and glucagon in single secretory granules.
    Ooi A; Katsuda S; Nakanishi I; Kameya T; Yamaguchi K; Kitamura H; Hayakawa Y
    Ultrastruct Pathol; 1989; 13(1):15-22. PubMed ID: 2537546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glucagon-secreting pancreatic alpha islet cell tumor presenting as spinal cord compression.
    Staren ED; Steinecker GA; Gould VE
    J Surg Oncol; 1987 Aug; 35(4):249-52. PubMed ID: 3039255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets.
    Petraki CD; Karavana VN; Revelos KI; Luo LY; Diamandis EP
    Histochem J; 2002; 34(6-7):313-22. PubMed ID: 12769263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glucagonoma with diabetic ketoacidosis; case report].
    Lefebvre J; Lelièvre G; Dalle-Furnari MA; Proye C; Mazzuca M; Garraud JC; Luyckx A; Linquette M
    Diabete Metab; 1982 Sep; 8(3):191-5. PubMed ID: 6292011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A malignant tumor of the pancreas producing glucagonoma syndrome: coexistence of glucagon and pancreatic polypeptide (PP) in the tumor cells.
    Bani D; Bani Sacchi T; Biliotti G
    Pancreas; 1989; 4(4):511-9. PubMed ID: 2548179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
    Elsborg L; Glenthøj A
    Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
    Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
    Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory granules in benign and malignant glucagonomas of the pancreas.
    Nakanishi I; Katsuda S; Kajikawa K; Yonemura Y; Konishi K; Miwa K
    Acta Pathol Jpn; 1984 Jan; 34(1):95-102. PubMed ID: 6328864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagonoma presenting as morbid obesity.
    Martin FM; Hamilton W; Dons R; Cashell AW; Ghosh BC
    J Surg Oncol; 1988 Dec; 39(4):256-9. PubMed ID: 2848156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatic tumor with diabetes and necrotic migratory erythema. Glucagonoma or proglucagonoma?].
    Gillet M; Rodier C; Quencez E; Laurent R; Mantion G; Landecy G; Nguyen N; Carbillet JP
    Chirurgie; 1988; 114(5):441-6. PubMed ID: 2852092
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
    Vandersteen PR; Scheithauer BW
    J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin analogue and tissue cultures in the study of a human malignant glucagonoma.
    Ahlman H; Ahlund L; Dahlström A; Grimelius L; Theodorsson E
    J Surg Oncol; 1990 Jul; 44(3):191-9. PubMed ID: 2164620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple hormone secretion by a human pancreatic glucagonoma in culture.
    White A; Tan K; Gray C; Roberts I; Ratcliffe JG
    Regul Pept; 1985 Aug; 11(4):335-45. PubMed ID: 2864720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nesidioblastosis coexisting with islet cell tumor and intraductal papillary mucinous hyperplasia.
    Zhao X; Stabile BE; Mo J; Wang J; French SW
    Arch Pathol Lab Med; 2001 Oct; 125(10):1344-7. PubMed ID: 11570912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.